Melissa McCracken
Directeur/Membre du Conseil chez TYRA BIOSCIENCES, INC.
Postes actifs de Melissa McCracken
Sociétés | Poste | Début | Fin |
---|---|---|---|
TYRA BIOSCIENCES, INC. | Directeur/Membre du Conseil | 01/03/2021 | - |
Independent Dir/Board Member | 01/03/2021 | - | |
Nextech Invest AG
Nextech Invest AG Investment ManagersFinance Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals. | Analyste en capital-investissement | 01/01/2019 | - |
Ambagon Therapeutics, Inc.
Ambagon Therapeutics, Inc. BiotechnologyHealth Technology Ambagon Therapeutics, Inc. provides healthcare services. It specializes in biotechnology. The company is headquartered in San Francisco, CA. | Directeur/Membre du Conseil | - | - |
Alpha-9 Oncology, Inc.
Alpha-9 Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Alpha-9 Theranostics, Inc. operates as a clinical stage radiopharmaceutical company. It engages in developing breakthrough targeting agents for cancer imaging by positron emission tomography (PET) and therapy using targeted radioisotopes. The company was founded by Fran?ois B?nard, David Perrin, Kuo-Shyan Lin, and Ian McBeath and is headquartered in Vancouver, Canada. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Melissa McCracken
Anciens postes connus de Melissa McCracken
Sociétés | Poste | Début | Fin |
---|---|---|---|
ImaginAb, Inc.
ImaginAb, Inc. Medical SpecialtiesHealth Technology ImaginAb, Inc. develops engineered antibody fragments for diagnostic imaging and novel therapeutic applications. It products offer actionable data to facilitate diagnosis of disease, inform better treatment decisions, and monitor response to therapy. The firm also offers a range of pre-clinical (animal imaging) reagents for use with microPET, microSPECT, and optical imaging systems. The company was founded by Christian P. Behrenbruch, Tove Olafsen, Anna M. Wu, and Robert E. Reiter in 2007 and is headquartered in Inglewood, CA. | Directeur/Membre du Conseil | - | - |
Formation de Melissa McCracken
University of California, Los Angeles | Doctorate Degree |
University of California, Davis | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 6 |
Suisse | 2 |
Canada | 2 |
Opérationnelle
Director/Board Member | 4 |
Private Equity Analyst | 1 |
Independent Dir/Board Member | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 3 |
Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
TYRA BIOSCIENCES, INC. | Health Technology |
Entreprise privées | 4 |
---|---|
Nextech Invest AG
Nextech Invest AG Investment ManagersFinance Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals. | Finance |
ImaginAb, Inc.
ImaginAb, Inc. Medical SpecialtiesHealth Technology ImaginAb, Inc. develops engineered antibody fragments for diagnostic imaging and novel therapeutic applications. It products offer actionable data to facilitate diagnosis of disease, inform better treatment decisions, and monitor response to therapy. The firm also offers a range of pre-clinical (animal imaging) reagents for use with microPET, microSPECT, and optical imaging systems. The company was founded by Christian P. Behrenbruch, Tove Olafsen, Anna M. Wu, and Robert E. Reiter in 2007 and is headquartered in Inglewood, CA. | Health Technology |
Ambagon Therapeutics, Inc.
Ambagon Therapeutics, Inc. BiotechnologyHealth Technology Ambagon Therapeutics, Inc. provides healthcare services. It specializes in biotechnology. The company is headquartered in San Francisco, CA. | Health Technology |
Alpha-9 Oncology, Inc.
Alpha-9 Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Alpha-9 Theranostics, Inc. operates as a clinical stage radiopharmaceutical company. It engages in developing breakthrough targeting agents for cancer imaging by positron emission tomography (PET) and therapy using targeted radioisotopes. The company was founded by Fran?ois B?nard, David Perrin, Kuo-Shyan Lin, and Ian McBeath and is headquartered in Vancouver, Canada. | Commercial Services |
- Bourse
- Insiders
- Melissa McCracken
- Expérience